Affirm Holdings, Inc. (AFRM) stock
AFRMNasdaqPersonal Credit InstitutionsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3093% above fair value
$65.84−2.00 (-2.95%)
Close on Nov 12, 2026Market cap $22.22BP/E 11.4Yield –
Affirm EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Affirm's EPS for the twelve months ending Sep 30, 2026 was $5.76, up 800.0% year over year. For fiscal 2026 it was $5.53, up 3586.7% from the year before. The highest annual figure on record is $5.53 in fiscal 2026.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $5.53 | +3586.7% |
| FY2025 | Jun 30, 2025 | $0.15 | – |
| FY2024 | Jun 30, 2024 | -$1.67 | – |
| FY2023 | Jun 30, 2023 | -$3.34 | – |
| FY2022 | Jun 30, 2022 | -$2.51 | – |
| FY2021 | Jun 30, 2021 | -$2.94 | – |
| FY2020 | Jun 30, 2020 | -$2.63 | – |
| FY2019 | Jun 30, 2019 | -$2.84 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $0.47 | +104.3% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $4.62 | +2617.6% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $0.30 | +2900.0% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $0.37 | +60.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $0.23 | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $0.17 | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $0.01 | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $0.23 | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$0.31 | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$0.14 | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$0.43 | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$0.54 | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$0.57 | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$0.69 | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$0.69 | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$1.10 | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$0.86 | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$0.65 | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$0.19 | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$0.57 | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$1.13 | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$0.61 | -183.6% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$1.23 | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$0.38 | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$0.47 | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $0.73 | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$1.80 | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$0.92 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?